To confirm whether Angpt2 administration could improve damage caused by ischemic injury, we first measured the blood flow before and during MCAO, analyzing brain sections through TTC and CV staining to assess the validity of the stroke model. This evidence concerns the gene ANGPT2 and Stroke.